 |
        |
|
Bridge Finance Group Provides $4.3 Million To Help Finance Growth Opportunity For Dayspring Pharma, LLC CHICAGO, IL – MARCH 7, 2007 - Bridge Finance Group funded a $3,300,000 Senior Term Loan and a $1,000,000 Revolving Line to DaySpring Pharma, LLC, a specialty pharmaceutical company. The credit facility allowed for the acquisition of the Brovex antihistamine product line from Athlon Pharmaceuticals and will provide working capital for operations. DaySpring is a niche focused pharmaceutical company with an emphasis on approved and late stage branded products, with a particular focus on the women’s health care and pediatrics fields. Wade Smith, CEO of DaySpring, said, "Bridge Finance Group was agile and creative with their financing solution. Their dedication and ability to move quickly and efficiently allowed us to capture a unique opportunity. We are excited to work with Bridge in the future as we continue to grow our business." “The management team of DaySpring has the ideal mix of experience and entrepreneurial spirit. We are looking forward to a strong partnership with this team, including working with the Company on additional acquisitions in the future.” noted Shawn Andrews, Managing Director of Bridge Finance Group. ABOUT BRIDGE FINANCE GROUP Bridge Finance Group offers a combination of comprehensive loan products, decades of financial expertise and an unparalleled service approach unique to the lending industry. Through accounts receivable, cash flow and real estate based term loan lending products, Bridge is able to address the differing capital needs of its customers. Bridge is based in Chicago, Illinois with offices in the Northeast, Southeast, and West Coast. Contact: Shawn Andrews, Managing Director |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
